| Regenerative medicine research at Pfizer. | |
| | |
MedLine Citation:
|
PMID: 21999263 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Interview with Ruth McKernan Ruth McKernan, Chief Scientific Officer at Pfizer Neusentis talks to Regenerative Medicine about the founding of Pfizer's regenerative medicine research program and explains what the recent restructure of the Unit will mean for regenerative medicine at Pfizer. Ruth McKernan is Chief Scientific Officer of Pfizer Neusentis. McKernan is a renowned neuroscientist, author of over 120 publications and a visiting Professor at King's College London. She graduated from the University of London with joint honors in biochemistry and pharmacology and gained her PhD studying the mechanism of action of antidepressant drugs. After 2 years as a researcher at University of California, San Diego she returned to the UK to start a successful career in the pharmaceutical industry. McKernan was instrumental in the creation of Pfizer Regenerative Medicine, hailed by many as the first major foray into the field by big pharma. |
| | |
Authors:
|
Ruth McKernan |
Related Documents
:
|
18750603 - Emergency medicine: activated charcoal-the first-line agent in cases of overdose. 18091593 - A survey of emergency department management of acute urticaria in children. 20830533 - Approach to the child with coma. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Regenerative medicine Volume: 6 ISSN: 1746-076X ISO Abbreviation: Regen Med Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-10-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101278116 Medline TA: Regen Med Country: England |
Other Details:
|
Languages: eng Pagination: 62-4 Citation Subset: IM |
Affiliation:
|
Pfizer Neusentis, Portway Building, Granta Park, Cambridge, CB21 6GS, UK. ruth.mckernan@pfizer.com. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mesenchymal stem cells in osteoarticular diseases.
Next Document: The Armed Forces Institute of Regenerative Medicine: a collaborative approach to Department of Defen...